Tiziana Life Sciences Ltd (TLSA) shareholders
Close on Nov 16, 2026Market cap $69.89MP/E –Yield –
Ownership
Who owns Tiziana Life Sciences's shares
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Laura Natalia Monica Fonda | 6,805,556 | 5.70% | 13G (passive) | Sep 12, 2025 |
| Chernett Jorey | 6,476,471 | 5.40% | 13G (passive) amendment | Sep 30, 2025 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Ivor Elrifi | Chief Executive Officer | 9,648,945 | 8.01% | Sep 29, 2026 |
| Keeren Rameshchandra Shah | CHIEF OPERATING & FIN. OFFICER | 2,500 | 0.00% | May 22, 2026 |
| Gabriele M. Cerrone | Director, 10% owner | 89,469,417 | 74.24% | Aug 7, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Ivor Elrifi Chief Executive Officer | Aug 15, 2026 | Option exercise | +1,050,000 | – | – | 5,843,684 |
| Ivor Elrifi Chief Executive Officer | Aug 5, 2026 | Buy | +237,616 | $1.00 | $237.62K | 4,793,684 |
| Ivor Elrifi Chief Executive Officer | Aug 4, 2026 | Buy | +83,807 | $0.97 | $81.29K | 4,556,068 |
| Ivor Elrifi Chief Executive Officer | Aug 3, 2026 | Buy | +667,000 | $1.00 | $667.00K | 4,472,261 |
| Gabriele M. Cerrone Director, 10% owner | Jul 21, 2026 | Buy | +42,357 | $0.99 | $41.93K | 44,814,587 |
| Gabriele M. Cerrone Director, 10% owner | Jul 21, 2026 | Award | +42,357 | $0.99 | $41.93K | 44,814,587 |
| Gabriele M. Cerrone Director, 10% owner | Jun 12, 2026 | Buy | +15,000 | $1.11 | $16.65K | 44,772,230 |
| Gabriele M. Cerrone Director, 10% owner | Jun 12, 2026 | Award | +15,000 | $1.11 | $16.65K | 44,772,230 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Tiziana Life Sciences's stock actually held short. Settlement fails (shares not delivered on time) peaked at 16,079 shares on Sep 11, 2026 over the last 90 days.
See a number that looks wrong?